2.99K
·
2025-08-01
Palantir Technologies (PLTR) Commerical Segment Growth and Guidance To Surprise For A Rally
$Palantir Technologies Inc.(PLTR)$ is scheduled to report its Q2 2025 earnings on Monday, August 4, 2025, after the market closes. As a high-growth, high-valuation stock, its earnings reports are often a significant catalyst for price movement. Analysts are largely optimistic about Palantir's Q2 performance, with a consensus expectation of continued strong growth. I am holding Palantir for long-term so the outlook guidance for every quarter earnings would need to be watched closely, as we have seen how PLTR shares decline after outlook does not seem to impress despite a stellar earnings performance. Revenue: The consensus estimate for Q2 revenue is around $938.3 million to $939.5 million. This would represent a substantial year-over-year growth of
TOPVenus Reade: After earnings on Monday, PE will be cut in half, so we can double stock price from here for the 3Q25 earnings. Yep!
6.52K
·
2025-08-01
💰 “Big Tech’s Trillion Dollar War: Microsoft Wins This Round—Apple or Nvidia Next?
Microsoft Enters the $4 Trillion Club! Who’s Next? I have always believed in the power of innovation, and this recent milestone proves it once again. When Microsoft crossed the $4 trillion market cap after an earnings beat, I felt reassured in my long-term holdings. I hold Microsoft because I see it not just as a software company, but as a foundational pillar in the AI revolution. Its enterprise dominance and tight integration of AI into Office, Azure, and Copilot give it enduring pricing power and recurring revenue. At the same time, I also hold Meta. When it surged 11% after smashing second-quarter forecasts and providing a bullish outlook, I saw the market affirm what I already knew: Meta’s ad empire is alive and well, and its AI infrastructure—from LLaMA to Quest and Ray-Ban AR—is posi
TOPMSFT gapped up from 52 week high $518, will it touch that price point again? Any truth to fill the gap?
3.14K
2.64K
5.96K
·
2025-07-31
$ADP 20250801 300.0 PUT$ ADP: took 99% of the maximum profit and close this short put trade ahead of its Friday expiry. ADP was trading close to strike if $300 and even opened 30th July Wed trading below at $299.31. Stock however went up higher on earning beats even though not by much and closed at $310.94. Took the chance to close the trade for profit as it might show some signs on weakness since stock didn't up higher by much despite earning beats and some others might sell it down to secure profit too. So I decided to do the same and not be a bag holder.
ADP PUT
07-30 23:14
US20250801 300.0
| Side | Price | Filled | Realized P&L |
|---|---|---|
| Buy Close | 0.05 1Lot(s) | +98.89% Closed |
4.96K
·
2025-07-31
NVIDIA’s Unique “Mini Triple Witching Day”
$NVIDIA(NVDA)$ What happens when options volume for the current week suddenly surges to triple witching levels in just a few days?On Wednesday, NVIDIA’s stock price rose 2%, and the open interest (OI) for the $NVDA 20250801 180.0 CALL expiring this week increased by 104,800 contracts, pushing its total OI to an astonishing 293,700 contracts!There are three call options expiring this week with OI exceeding 100,000 contracts:$NVDA 20250801 180.0 CALL: 293,700 contracts$NVDA 20250801 182.5 CALL: 149,000 contracts$NVDA 20250801 185.0 CALL: 117,000 contractsTo put this into perspective, let’s compare it to the June 20 triple witching day:On June 20, there were four call strikes with OI exceeding 100,000 contracts: $NVDA 20250620 150.0 CALL, 145.0 CALL,
5.48K
·
2025-07-31
$OSCR 20250815 16.0 CALL$ Closing covered call early with the extension of ACA and earnings on 6 Aug which seems bullish. Will wait for the catalyst to push the stock higher before selling covered call at a higher strike. Thanks for the #CaiFanMoney.
OSCR CALL
07-31 21:56
US20250815 16.0
| Side | Price | Filled | Realized P&L |
|---|---|---|
| Buy Close | 0.60 15Lot(s) | +41.76% Closed |
TOPNice strategy, managing your risk with Covered call[Cool]
8.71K
·
2025-07-31
$ADBE 20250919 290.0 PUT$ Figma may cause it to be unstable short term willl get into figma option when available . Getting profits out first
ADBE PUT
07-31 22:36
US20250919 290.0
| Side | Price | Filled | Realized P&L |
|---|---|---|
| Buy Close | 2.00 1Lot(s) | +34.03% Closed |
TOPAdobe is in trouble given AI capabilities will relegate many Adobe products obsolete. Plus FIGMA is a real competitor.
2.02K
3.67K
·
2025-07-31
AI BOOMS: META& SOFI
Hello everyone! Today i want to share some trading ideas with you!1.Everybody is upset with $SoFi Technologies Inc.(SOFI)$ $1.5 billion shelf offering.I am comfortable with it. I am sure that they’ll make a very good use of that money and increase shareholder value more than the dilution.Anthony Noto himself gets $53 million worth of rewards if the average closing price over the 90-day period is above $25.If you think he is diluting you for nothing on the day the stock tested $25 levels, you have learnt nothing about him.I think they’ll likely use the money for a crypto related acquisition in which case return will way exceed the loss from dilution.Image2.Energy demand in both the US and EU grew sharply after 2023.Goldman Sachs projects that the d
4.32K
·
2025-07-31
COIN: IPO Break at $429 Can Send Stock To $600 By Year End
$Coinbase Global, Inc.(COIN)$ IPO Break at $429 Can Send Stock To $600 By Year End📈 We finally broke out of the 7 month bull flag range back in June and tested the IPO high of 430. We couldn't hold long above 430, but looks like we are setting up to retest the IPO high and possibly breakout into a multi-month move. If we break and hold above 430 we can see 600 by year-end!Growth DriversCoinbase is the backbone custodian/prime broker for BTC & ETH spot ETFs, benefitting directly from continued institutional inflows,Explosive growth in USDC revenue, recurring subs (Coinbase One), and derivatives (U.S. perps now live),Onchain growth via Base + strengthened institutional custody credibility with BlackRock & ETH ETF partners,Recent Developments
3.63K
·
2025-07-31
Why Can Open Interest in Options Be Negative? | #OptionsHandbook EP005
In options trading, you’re not just limited to buying—you can be the seller too! Take Sell Call as an example: once you sell a call, your position shows “-1”. Many beginners stumble when it comes to the seller’s role. That’s why the Options Handbook breaks it down clearly— ▶ Welcome to the Writer's Seat! You can sell an option in the options market even if you do not own one. Like short-selling stocks, you do not need to hold the asset to trade it. In fact, selling an option is simpler than shorting a stock; you do not need to borrow anything. Instead, you "write" the option, which is why selling options is often called writing options. ▶ How It Works? You post a sell order for an option on the pl
3.62K
·
2025-07-31
Nvidia Up 2.1%—What’s the Options Play Now? | #OptionsHandbook EP004
$英伟达(NVDA)$ stock gained 2.1% on Wednesday. Morgan Stanley analysts are confident the stock has more to gain, raising their target price to $200 from $170. Nvidia is a classic case of a large-cap, highly liquid stock with clear fundamentals—making it one of the most popular underlying stocks for options trading. Whether you're bullish, bearish, or neutral, options offer strategies to express your market view! ▶ Bullish on Nvidia? You could buy a $185 Call expiring Aug 15 for around $2.76. If the stock climbs past $185, your option is in the money. Your breakeven is $187.26 — anything above that means a profit. Or exit early and take profits anytime. ▶ Prefer selling? You could write a $185 Call expiring Aug 15 and pocket $2.76 in premium. If Nvidi
4.96K
·
2025-07-31
I am impressed by Microsoft's $Microsoft(MSFT)$
1.92K
4.77K
·
2025-07-31
ER: TT, LRCX, MSFT& QCOM
Hello everyone! Today i want to share some ER with you!1. $Trane Technologies PLC(TT)$ Announced Q2 Non-GAAP EPS of $3.88 per share, beating estimates by $0.09, on revenue of $5.75B which missed the consensus by $20M, but was a YoY increase of 7.7%. Additionally, weak demand in the Asia market overshadowed the EPS growth, as shares were down about 8% in midday trading.2. $Lam Research(LRCX)$ Announced Q4 normalized EPS of $1.33, beating analyst expectations by $0.12, on revenue of $5.17B, which also topped the consensus by $170M, and was a whopping 34% increase from the same period a year ago. Shares are up 4% in after-hours trading.3. $Microsoft(MSFT)$ crushed Q4
13.85K
·
2025-07-31
July Wrap-Up: After 4-Month Gains, Will August Fall into Which Scenario?
As July trading officially comes to a close, U.S. stocks delivered a solid "summer report card": $NASDAQ(.IXIC)$ rose for a fourth consecutive month, gaining 3.70% in July. $S&P 500(.SPX)$ climbed 2.17%. Market sentiment remains supported by crypto strength and AI-driven optimism.🗓 A Look at Historical Trends: August Isn’t Bearish, but Volatility Tends to RiseWhen July ended with gains, August followed with gains 14 times — a 70% probability.However, August is also one of the most volatile months seasonally, especially in post-election years, where the first eight trading days tend to be weak.⚠️ But it’s September that truly earns the “danger month” title:In the past 24 years, 15 Septembers ended in
TOPAugust will be the month for Corrections 😁 as there is a Chinese saying of Qishang 👆 eight times 👇[Chuckle][Chuckle][Chuckle]Must follow the rhythm. Of course, the On the other hand, Markets have Risen to an extreme, so be prepared for a correction. 😉 @JC888 @Barcode @yourcelesttyy @koolgal @Shyon @Shernice軒嬣 2000
1.51K
·
2025-07-31
MSFT: Another AI King!
Hello everyone! Today i want to share some trading ideas with you!1.Delivered 😏 $Microsoft(MSFT)$ • Sales $76.4B vs Est. $73.8B• EPS $3.65 vs Est. $3.38• Cloud Sales $29.9B vs Est. $29.1BImage2.STILL QUESTIONING THE AI BOOM?I know a lot of people are still wondering if all this AI hype is actually turning into real business -- but just look at Azure this quarter.They added $4.3B in net new cloud revenue -- that’s more than double any other quarter in $Microsoft(MSFT)$ history.ImageFor whom haven't open CBA can know more from below:🏦 Open a CBA today and enjoy privileges of up to SGD 20,000 in trading limit with 0 commission. Trade SG, HK, US stocks as well as ETFs unlimitedly!Find out more here：
7.61K
·
2025-07-31
Costly Resolvement Haunts Seatrium: Dip Buying Chance?
$Seatrium Ltd(5E2.SI)$ fell 5.42% today, closing at S$2.27, even after delivering a strong set of results for the first half of 2025.Net profit of S$144.4 million, up over 300% yoy, marking the second time it has achieved a first-half profit since its restructuring.Revenue rose 33.7% to S$5.4 billion, and gross profit margin improved from 3.7% to 7.4%.EBITDA climbed 31% to S$407 million.EPS increased to S$0.0426Maintained its policy of not declaring an interim dividend.As of end-June, Seatrium held a net order backlog of S$18.6 billion, with 34% of it tied to renewable energy and green projects.Seatrium resolves fines linked to Brazilian corruption probe - Splash247Why did the stock drop despite strong earnings?Market concerns linger over the ma
TOPSeatrium’s $Seatrium Ltd(5E2.SI)$ 5.42% drop today surprised me, especially after strong results — net profit up over 300%, revenue up 33.7%, and margins improving. I think the market is still reacting to the S$240 million fine from the Brazilian probe, even though it was already provisioned and won’t affect FY2025 profit. The reputational concerns likely triggered short-term selling. That said, I see long-term value. With a S$18.6 billion order backlog and 34% tied to green projects, Seatrium is well-positioned for recovery. Citibank’s target price of S$2.65 adds to my confidence. I’m also watching Sembcorp for its clean energy focus & consistent track record. In terms of oversold plays, I think $SIA(C6L.SI)$ looks interesting. Despite a solid recovery in travel and strong passenger load factors, the stock has been under pressure lately. With travel demand still high and cargo improving, I believe the dip could be a buying opportunity. @Tiger_SG @Tiger_comments @TigerStars
5.10K
·
2025-07-31
$LEADS BIOLABS-B(09887)$ stands out with its clinical-driven approach and leading pipeline, offering huge potential with minimal competition. Its expertise in bispecific antibodies and TCE fields unlocks a blue ocean market. Let’s ride the growth wave for steady gains together!